A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer

被引：0
|
作者：
Steven J. Cohen
Mark M. Zalupski
Manuel R. Modiano
Paul Conkling
Yehuda Z. Patt
Peg Davis
Robert T. Dorr
Michelle L. Boytim
Evan M. Hersh
机构：
[1] Fox Chase Cancer Center,Department of Medical Oncology
[2] University of Michigan,undefined
[3] Arizona Clinical Research Center,undefined
[4] Virginia Oncology Associates,undefined
[5] US Oncology Phase I Group,undefined
[6] University of New Mexico,undefined
[7] University of Arizona,undefined
[8] AmpliMed Corporation,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2010年 / 66卷
关键词：
Gemcitabine; Imexon; Pancreatic cancer; Phase I clinical trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：287 / 294
页数：7
相关论文
共 50 条
  • [1] A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer
    Cohen, Steven J.
    Zalupski, Mark M.
    Modiano, Manuel R.
    Conkling, Paul
    Patt, Yehuda Z.
    Davis, Peg
    Dorr, Robert T.
    Boytim, Michelle L.
    Hersh, Evan M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (02) : 287 - 294
  • [2] A phase I study of imexon inj plus gemcitabine as first-line therapy for advanced pancreatic cancer with preclinical mechanistic study of dose limiting toxicity
    Cohen, S. J.
    Zalupski, M. M.
    Modiano, M. R.
    Conkling, P. R.
    Patt, Y. Z.
    Davis, P.
    Dorr, R. T.
    Boytim, M. L.
    Hersh, E. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] A phase II study of gemcitabine plus nab-paclitaxel as first-line therapy for locally advanced pancreatic cancer
    Fukahori, Masaru
    Miwa, Keisuke
    Murotani, Kenta
    Naito, Yoshiki
    Ushijima, Tomoyuki
    Sakaue, Takahiko
    Tanaka, Toshimitsu
    Nagasu, Sachiko
    Suga, Hideya
    Kakuma, Tatsuyuki
    Okabe, Yoshinobu
    Torimura, Takuji
    MEDICINE, 2021, 100 (20) : E26052
  • [4] Gemcitabine Plus Irinotecan as First-Line Weekly Therapy in Locally Advanced and/or Metastatic Pancreatic Cancer
    Neri, B.
    Cipriani, G.
    Grifoni, R.
    Molinara, E.
    Pantaleo, P.
    Rangan, S.
    Vannini, A.
    Tonelli, P.
    Valeri, A.
    Pantalone, D.
    Taddei, A.
    Bechi, P.
    ONCOLOGY RESEARCH, 2009, 17 (11-12) : 559 - 564
  • [5] Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial
    Fogelman, David
    Jafari, Mehrdad
    Varadhachary, Gauri R.
    Xiong, Henry
    Bullock, Susie
    Ozer, Harold
    Lin, E.
    Morris, Jeffrey
    Cunningham, Patti
    Bennett, Bronwyn
    Abbruzzese, James L.
    Wolff, Robert A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (06) : 1431 - 1438
  • [6] Gemcitabine confirmed as the first-line therapy for pancreatic cancer
    Claire Greenhill
    Nature Reviews Gastroenterology & Hepatology, 2011, 8 (1) : 3 - 3
  • [7] Efficacy of nimotuzumab plus gemcitabine usage as first-line treatment in patients with advanced pancreatic cancer
    Su, Dan
    Jiao, Shun-Chang
    Wang, Li-Jie
    Shi, Wei-Wei
    Long, Yan-Yan
    Li, Juan
    Bai, Li
    TUMOR BIOLOGY, 2014, 35 (03) : 2313 - 2318
  • [8] Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study
    Kyung Hee Lee
    Min Kyoung Kim
    Yeol Hong Kim
    Baek Yeol Ryoo
    Ho Yeong Lim
    Hong Suk Song
    Hoon Kyo Kim
    Myung Ah Lee
    Seock Ah Im
    Heung Moon Chang
    Jae Yong Cho
    Dae Young Zang
    Bong Seog Kim
    Jun Suk Kim
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 317 - 325
  • [9] Gemcitabine and oxaliplatin combination as the first-line treatment in advanced pancreatic cancer: A multicenter phase II study
    Lee, K.
    Kim, M.
    Kim, Y.
    Ryoo, B.
    Lim, H.
    Song, H.
    Kim, H.
    Lee, M.
    Im, S.
    Chang, H.
    Cho, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study
    Lee, Kyung Hee
    Kim, Min Kyoung
    Kim, Yeol Hong
    Ryoo, Baek Yeol
    Lim, Ho Yeong
    Song, Hong Suk
    Kim, Hoon Kyo
    Lee, Myung Ah
    Im, Seock Ah
    Chang, Heung Moon
    Cho, Jae Yong
    Zang, Dae Young
    Kim, Bong Seog
    Kim, Jun Suk
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (02) : 317 - 325
12345